Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2013-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1586/14737175.2013.811981PMID 23898853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased BDNF levels in long-term bipolar disorder patients.

  2013cited by this paper
• Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

  2013cited by this paper
• Chemokines in bipolar disorder: Trait or state?

  2013cited by this paper
• The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder

  2013cited by this paper
• Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors

  2013cited by this paper
• Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder

  2013cited by this paper
• Oxidative stress and therapeutic implications in psychiatric disorders.

  2013cited by this paper
• Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies.

  2013cited by this paper
• Is bipolar disorder an inflammatory condition? The relevance of microglial activation

  2013cited by this paper
• Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression.

  2013cited by this paper
• Impaired mitochondrial function in psychiatric disorders

  2012cited by this paper
• Can bipolar disorder be viewed as a multi-system inflammatory disease?

  2012cited by this paper
• Mediators of allostasis and systemic toxicity in bipolar disorder.

  2012cited by this paper
• One‐year psychosocial functioning in patients in the early vs. late stage of bipolar disorder

  2012cited by this paper
• Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

  2012cited by this paper
• Immuno- inflammatory markers of bipolar disorder: a review of evidence.

  2012cited by this paper
• Staging and Neuroprogression in Bipolar Disorder

  2012cited by this paper
• ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres

  2012cited by this paper
• Microglia in the developing brain: a potential target with lifetime effects.

  2012cited by this paper
• Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling.

  2012cited by this paper
• Minocycline: therapeutic potential in psychiatry.

  2012cited by this paper
• Reactive oxygen species and ischemic cerebrovascular disease.

  2012cited by this paper
• Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

  2012cited by this paper
• Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

  2012cited by this paper
• Endoplasmic Reticulum Stress and Inflammation

  2012cited by this paper
• Serum Protein Levels of Brain-Derived Neurotrophic Factor and Tropomyosin-Related Kinase B in Bipolar Disorder: Effects of Mood Stabilizers

  2012cited by this paper
• Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.

  2012cited by this paper
• Evidence for an association between tumor necrosis factor-alpha levels and lithium response.

  2012cited by this paper
• Molecular mechanisms of superoxide production by the mitochondrial respiratory chain.

  2012cited by this paper
• State‐related alterations of gene expression in bipolar disorder: a systematic review

  2012cited by this paper
• Neurobiological correlates of illness progression in the recurrent affective disorders.

  2012cited by this paper
• Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.

  2012cited by this paper
• Glial cells in (patho)physiology

  2012cited by this paper
• Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder

  2012cited by this paper
• N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.

  2011cited by this paper
• The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

  2011cited by this paper
• Stress- and allostasis-induced brain plasticity.

  2011cited by this paper
• Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study.

  2011cited by this paper
• Circulating levels of GDNF in bipolar disorder.

  2011cited by this paper
• Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.

  2011cited by this paper
• N-Acetylcysteine prevents baker’s-yeast-induced inflammation and fever

  2011cited by this paper
• Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models

  2011cited by this paper
• Cardiovascular Morbidity and Mortality in Bipolar Disorder

  2011cited by this paper
• Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.

  2011cited by this paper
• Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival

  2011cited by this paper
• Therapeutic use of omega-3 fatty acids in bipolar disorder

  2011cited by this paper
• Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.

  2011cited by this paper
• Effects of lithium on oxidative stress parameters in healthy subjects.

  2011cited by this paper
• ER stress modulates cellular metabolism.

  2011cited by this paper
• Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder.

  2011cited by this paper
• Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

  2011cited by this paper
• Role of glucose-regulated Protein 78 in embryonic development and neurological disorders.

  2011cited by this paper
• Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.

  2011cited by this paper
• N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

  2011cited by this paper
• Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain.

  2011cited by this paper
• Peripheral biomarkers and illness activity in bipolar disorder.

  2011cited by this paper
• Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders

  2011cited by this paper
• N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs?

  2011cited by this paper
• Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury.

  2011cited by this paper
• N-acetylcysteine for major depressive episodes in bipolar disorder.

  2011cited by this paper
• Free radicals and antioxidants - quo vadis?

  2011cited by this paper
• Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells.

  2011cited by this paper
• Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

  2010cited by this paper
• Bipolar disorder and metabolic syndrome: an international perspective.

  2010cited by this paper
• Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Excellent lithium responders have normal cognitive functions and plasma BDNF levels.

  2010cited by this paper
• Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.

  2010cited by this paper
• Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models

  2010cited by this paper
• Brain oxidative stress after dermal and subcutaneous exposure of T-2 toxin in mice.

  2010cited by this paper
• Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.

  2010cited by this paper
• Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients.

  2010cited by this paper
• Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.

  2010cited by this paper
• Allostatic load biomarkers of chronic stress and impact on health and cognition.

  2010cited by this paper
• Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder.

  2010cited by this paper
• Evidence and implications for early intervention in bipolar disorder

  2010cited by this paper
• Cytokine levels in euthymic bipolar patients.

  2010cited by this paper
• Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers.

  2010cited by this paper
• Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes.

  2010cited by this paper
• Glial cell line-derived neurotrophic factor is increased in cerebrospinal fluid but decreased in blood during long-term pain

  2010cited by this paper
• Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

  2010cited by this paper
• A systemic toxicity index developed to assess peripheral changes in mood episodes

  2010cited by this paper
• Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

  2010cited by this paper
• Mood-stabilizers target the brain arachidonic acid cascade.

  2009cited by this paper
• Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

  2009cited by this paper
• Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.

  2009cited by this paper
• Increased Serum Neurotrophin-4/5 Levels in Bipolar Disorder

  2009cited by this paper
• Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue.

  2009cited by this paper
• Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder.

  2009cited by this paper
• Structural and functional link between the mitochondrial network and the endoplasmic reticulum.

  2009cited by this paper
• The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long‐term prognosis?

  2009cited by this paper
• SR/ER-mitochondrial local communication: calcium and ROS.

  2009cited by this paper
• Mania and mortality: Why the excess cardiovascular risk in bipolar disorder?

  2009cited by this paper
• Functioning and Disability in Bipolar Disorder: An Extensive Review

  2009cited by this paper
• Biodegradable polymer-metal complexes for gene and drug delivery.

  2009cited by this paper
• Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.

  2009cited by this paper
• Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study.

  2009cited by this paper
• A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

  2009cited by this paper
• Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.

  2009cited by this paper
• Neurocognitive impairment in bipolar disorder patients: functional implications.

  2009cited by this paper

• Future Pharmacotherapy for Bipolar Disorders: Emerging Trends and Personalized Approaches

  2025cites this paper
• Association of bipolar disorder with new-onset delirium among critically ill patients.

  2025cites this paper
• Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative review

  2024cites this paper
• Accurate identification of genes associated with brain disorders by integrating heterogeneous genomic data into a Bayesian framework

  2024cites this paper
• Peripheral inflammation is associated with impaired sadness recognition in euthymic bipolar patients.

  2024cites this paper
• Thiol-disulphide homeostasis, ischemia-modified albumin, complete blood count-derived inflammatory markers and C-reactive protein from acute mania to early remission in bipolar disorder.

  2023cites this paper
• Upotreba suplemenata u tretmanu pacijenata sa bipolarnim poremećajem

  2023cites this paper
• Immune Cell Ratios Are Higher in Bipolar Affective than Unipolar Depressive Disorder and Modulated by Mood Episode: A Retrospective, Cross-Sectional Study

  2023cites this paper
• Neuroprogression in bipolar disorder

  2022cites this paper
• Comparative efficacy, acceptability, and tolerability of adjunctive anti-inflammatory agents on bipolar disorder: A systemic review and network meta-analysis.

  2022cites this paper
• The Role of Equilibrium between Free Radicals and Antioxidants in Depression and Bipolar Disorder

  2022cites this paper
• Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?—A Narrative Review

  2022cites this paper
• Neuroinflammation and neuroprogression produced by oxidative stress in euthymic bipolar patients with different onset disease times

  2022cites this paper
• Elevation of C-reactive protein in adolescent bipolar disorder vs. anxiety disorders.

  2022cites this paper
• Systematic evaluation of the associations between mental disorders and dementia: An umbrella review of systematic reviews and meta-analyses.

  2022cites this paper
• Can we prevent the neuroinflammation and neuroprogression produced by oxidative stress in euthymic bipolar patients, using mood stabilizers?

  2022cites this paper
• Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder

  2021cites this paper
• Update on Statin Treatment in Patients with Neuropsychiatric Disorders

  2021cites this paper
• Molecular aspects of regeneration and neuroprotection in neuropsychiatric diseases

  2021cites this paper
• Biological Pathways Associated with Neuroprogression in Bipolar Disorder

  2021cites this paper
• Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratio in Bipolar Disorder

  2021cites this paper
• Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta‐analyses

  2020cites this paper
• Differences in mitochondrial DNA copy number between patients with bipolar I and II disorders.

  2020cites this paper
• BIOQUÍMICA MITOCONDRIAL E ESTRESSE OXIDATIVO NO TRANSTORNO BIPOLAR: NOVOS HORIZONTES

  2020cites this paper
• Does single gene expression omnibus data mining analysis apply for only tumors and not mental illness? A preliminary study on bipolar disorder based on bioinformatics methodology

  2020cites this paper
• Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder

  2020cites this paper
• Oxidative stress biomarkers in bipolar disorder with suicidal behavior: A systematic review

  2019cites this paper
• Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach

  2019influential citation
• Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape

  2019cites this paper
• Bipolar disorder: genetic analysis of the circadian rhythm associated genes and metabolic syndrome

  2019influential citation
• High BDNF serum levels are associated to good cognitive functioning in bipolar disorder

  2019cites this paper
• Predicting individual responses to lithium with oxidative stress markers in drug-free bipolar disorder

  2019cites this paper
• Efeito da administração intravenosa repetida de lidocaína associada à pregabalina em pacientes fibromiálgicas: evidências sobre o estresse oxidativo

  2019cites this paper
• Potential Use of Stem Cells in Mood Disorders.

  2018cites this paper
• Differential mitochondrial DNA copy number in three mood states of bipolar disorder

  2018cites this paper
• A multisystem composite biomarker as a preliminary diagnostic test in bipolar disorder

  2018cites this paper
• White matter volume is decreased in bipolar disorder at early and late stages.

  2018cites this paper
• Telomere Length, Oxidative Stress, Inflammation and BDNF Levels in Siblings of Patients with Bipolar Disorder: Implications for Accelerated Cellular Aging

  2017cites this paper
• Mitochondrial DNA sequence data reveals association of haplogroup U with psychosis in bipolar disorder.

  2017cites this paper
• Brain-Derived Neurotrophic Factor (Bdnf) and Gray Matter Volume in Bipolar Disorder

  2017cites this paper
• Mood Disorders and Severe Obesity: A Case Study

  2017cites this paper
• The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine

  2017cites this paper
• Staging Models in Bipolar Disorder: A Systematic Review of the Literature

  2016cites this paper
• State-dependent increase in the levels of neurotrophin-3 and neurotrophin-4/5 in patients with bipolar disorder: A meta-analysis.

  2016cites this paper
• Peripheral adenosine levels in euthymic patients with bipolar disorder.

  2016cites this paper
• Preventing intellectual disability during pregnancy: what are the potentially high yield targets?

  2016cites this paper
• Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample

  2016cites this paper
• Dentate gyrus−cornu ammonis (CA) 4 volume is decreased and associated with depressive episodes and lipid peroxidation in bipolar II disorder: Longitudinal and cross‐sectional analyses

  2016cites this paper
• Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology

  2016cites this paper
• Exploración de un modelo de estadiaje clínico aplicado al trastorno bipolar

  2015cites this paper
• Neuroprogression and Staging in Bipolar Disorder

  2015cites this paper
• Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation

  2015cites this paper
• Violent suicidal behaviour in bipolar disorder is associated with nitric oxide synthase 3 gene polymorphism

  2015cites this paper
• Effects of a single bout of maximal aerobic exercise on BDNF in bipolar disorder: A gender-based response.

  2015cites this paper
• Staging bipolar disorder: what data and what models are needed?

  2015cites this paper
• The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases

  2015cites this paper
• Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

  2015influential citation
• Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders.

  2015cites this paper
• Neurobiological Clues of Risk for Bipolar Disorder Development

  2014cites this paper
• Interventions for Youth at Risk of Bipolar Disorder

  2014cites this paper
• Biomarkers and staging of bipolar disorder: a systematic review.

  2014cites this paper
• Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia

  2014cites this paper
• Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania.

  2014cites this paper
• Lovastatin as an Adjuvant to Lithium for Treating Manic Phase of Bipolar Disorder: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2014cites this paper
• Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care.

  2013cites this paper
• Toward Clinically Applicable Biomarkers in Bipolar Disorder: Focus on BDNF, Inflammatory Markers, and Endothelial Function

  2013cites this paper